FREE Top 5 ASX Stocks for October 2026 Download Free Report
ASX 200

Checkout Our Recommendation for free - 7 days free trial

Subscribe Now
ASX:IPD

Impedimed Ltd - IPD share price

$ - -
-

About Impedimed Ltd

ImpediMed Limited, an Australian medical technology company, specializes in bioimpedance spectroscopy (BIS) systems for early detection of conditions like lymphoedema and heart failure. Their SOZO platform measures fluid status and tissue composition, aiding clinicians in managing chronic diseases. They offer devices like SFB7 for clinical and research use and ImpediVET for veterinary applications. SOZO applications include L-Dex Analysis for Lymphedema, BodyComp Analysis, Segmental BodyComp Analysis, and HF-Dex Analysis for Heart Failure.

Company Profile

Market Cap -
Book Value -

Enterprise Value -
Revenue TTM -

Shares Outstanding -
Earning Share -

Shares Float -
Dividend per Share -

P/E Ratio -
Div Yield -

Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.

Price Summary

Today's Low Today's High
- -
52 Week High
-
52 Week Low
-
Limited Offer
Try Veye Free for 7 Days

Expert ASX stock picks, in-depth research & buy/sell signals — free for a full week.

Start Free Trial

No credit card required

Price Chart (IPD)

TOP ASX STOCKS Worth Watching

  • ✓ Instant Access
  • ✓ No Credit Card Required
  • ✓ Free to join · No spam
Get Free Report on WhatsApp

Free to join · No spam · Unsubscribe anytime

By providing your details, you agree to Veye's Terms & Conditions, Privacy Policy, and Financial Services Guide and to receive marketing offers. Before you access our services, please read the Financial Services Guide available here.

Special Research Report

Discover the Top ASX Stocks to Invest in 2026!

Expert Analysis of Top-Performing ASX Stocks
Market Insights and In-Depth Research
Buy, Sell, And Hold Recommendations

Almost There!

Enter your details to download the report

Success!

Preparing your download...